Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats

被引:83
|
作者
Jose Zarzuelo, Maria [1 ]
Jimenez, Rosario [1 ,3 ]
Galindo, Pilar [1 ]
Sanchez, Manuel [1 ]
Nieto, Ana [4 ]
Romero, Miguel [1 ]
Maria Quintela, Ana [1 ]
Lopez-Sepulveda, Rocio [1 ]
Gomez-Guzman, Manuel [1 ]
Bailon, Elvira [1 ]
Rodriguez-Gomez, Isabel [2 ]
Zarzuelo, Antonio [1 ,5 ]
Galvez, Julio [1 ,5 ]
Tamargo, Juan [6 ]
Perez-Vizcaino, Francisco [6 ,7 ,8 ]
Duarte, Juan [1 ]
机构
[1] Univ Granada, Sch Pharm, Dept Pharmacol, E-18071 Granada, Spain
[2] Univ Granada, Sch Med, Dept Physiol, E-18071 Granada, Spain
[3] Ctr Biomed Res, Granada, Spain
[4] Anapath, Anat Pathol Lab, Granada, Spain
[5] Ciber Enfermedades Hepat & Digest, Madrid, Spain
[6] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain
[7] Ciber Enfermedades Resp, Madrid, Spain
[8] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
关键词
PPAR beta/delta; spontaneously hypertensive rat; endothelial dysfunction; NADPH oxidase; regulators of G protein-coupled signaling proteins; PROTEIN-KINASE-C; ANGIOTENSIN-II; OXIDATIVE STRESS; FATTY-ACID; PPAR-ALPHA; KAPPA-B; EXPRESSION; ENDOTHELIN-1; HEART; HYPERTROPHY;
D O I
10.1161/HYPERTENSIONAHA.111.174490
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta) has been shown to improve insulin resistance and plasma high-density lipoprotein levels, but nothing is known about its effects in genetic hypertension. We studied whether the PPAR beta agonist GW0742 might exert antihypertensive effects in spontaneously hypertensive rats (SHRs). The rats were divided into 4 groups, Wistar Kyoto rat-control, Wistar Kyoto rat-treated (GW0742, 5 mg . kg(-1) . day(-1) by oral gavage), SHR-control, and SHR-treated, and followed for 5 weeks. GW0742 induced a progressive reduction in systolic arterial blood pressure and heart rate in SHRs and reduced the mesenteric arterial remodeling, the increased aortic vasoconstriction to angiotensin II, and the endothelial dysfunction characteristic of SHRs. These effects were accompanied by a significant increase in endothelial NO synthase activity attributed to upregulated endothelial NO synthase and downregulated caveolin 1 protein expression. Moreover, GW0742 inhibited vascular superoxide production, downregulated p22(phox) and p47(phox) proteins, decreased both basal and angiotensin II-stimulated NADPH oxidase activity, inhibited extracellular-regulated kinase 1/2 activation, and reduced the expression of the proinflammatory and proatherogenic genes, interleukin 1 beta, interleukin 6, or intercellular adhesion molecule 1. None of these effects were observed in Wistar Kyoto rats. PPAR beta activation, both in vitro and in vivo, increased the expression of the regulators of G protein-coupled signaling proteins RGS4 and RGS5, which negatively modulated the vascular actions of angiotensin II. PPAR beta activation exerted antihypertensive effects, restored the vascular structure and function, and reduced the oxidative, proinflammatory, and proatherogenic status of SHRs. We propose PPAR beta as a new therapeutic target in hypertension. (Hypertension. 2011;58:733-743.)
引用
收藏
页码:733 / U437
页数:23
相关论文
共 50 条
  • [1] Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation
    Toral, Marta
    Romero, Miguel
    Perez-Vizcaino, Francisco
    Duarte, Juan
    Jimenez, Rosario
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 312 (02): : H189 - H200
  • [2] Peroxisome proliferator-activated receptor-γ mediates the antihypertensive effects of acupuncture in spontaneously hypertensive rats
    Fan, Hao
    Yang, Jing-Wen
    Huang, Jin
    Wang, Lu
    Yang, Na-Na
    Tu, Jian-Feng
    Liu, Cun-Zhi
    NEUROREPORT, 2020, 31 (13) : 952 - 958
  • [3] Effects of peroxisome proliferator-activated receptor- activation in endothelin-dependent hypertension
    Jose Zarzuelo, Maria
    Gomez-Guzman, Manuel
    Jimenez, Rosario
    Maria Quintela, Ana
    Romero, Miguel
    Sanchez, Manuel
    Zarzuelo, Antonio
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Duarte, Juan
    CARDIOVASCULAR RESEARCH, 2013, 99 (04) : 622 - 631
  • [4] Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
    Maria Quintela, Ana
    Jimenez, Rosario
    Gomez-Guzman, Manuel
    Jose Zarzuelo, Maria
    Galindo, Pilar
    Sanchez, Manuel
    Vargas, Felix
    Cogolludo, Angel
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Duarte, Juan
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) : 730 - 741
  • [5] Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive rats
    Sun, Yanru
    Han, Mingfeng
    Shen, Zhenhuang
    Huang, Haibo
    Miao, Xiaoqing
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2018, 25 (02) : 213 - 219
  • [6] Peroxisome proliferator-activated receptor-α activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats
    Shin, Seok Joon
    Lim, Ji Hee
    Chung, Sungjin
    Youn, Dong-Ye
    Chung, Hyun Wha
    Kim, Hyung Wook
    Lee, Jeong-Hwa
    Chang, Yoon Sik
    Park, Cheol Whee
    HYPERTENSION RESEARCH, 2009, 32 (10) : 835 - 845
  • [7] Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis
    Misra, Parimal
    Reddy, Janardan K.
    BIOCHIMIE, 2014, 98 : 63 - 74
  • [8] Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats
    Su, Xuesong
    Yu, Rui
    Yang, Xu
    Zhou, Guangyu
    Wang, Yanqiu
    Li, Li
    Li, Detian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (06) : 671 - 679
  • [9] Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes
    Pang, Wei
    Li, Nan
    Ai, Ding
    Niu, Xiao-Lin
    Guan, You-Fei
    Zhu, Yi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (06) : 358 - 364
  • [10] Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids
    Zhu, Bokai
    Zhu, Xiaoyang
    Borland, Michael G.
    Ralph, Douglas H.
    Chiaro, Christopher R.
    Krausz, Kristopher W.
    Ntambi, James M.
    Glick, Adam B.
    Patterson, Andrew D.
    Perdew, Gary H.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    BIOMOLECULES, 2024, 14 (06)